NeuroPace, Inc. NPCE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.01% | 19.24% | 14.84% | 13.33% | 11.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.01% | 19.24% | 14.84% | 13.33% | 11.88% |
| Cost of Revenue | 15.75% | 1.42% | -10.31% | -10.33% | -6.29% |
| Gross Profit | 25.02% | 24.86% | 23.70% | 21.72% | 18.21% |
| SG&A Expenses | 10.69% | 17.79% | 12.99% | 11.43% | 6.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.39% | 12.52% | 9.36% | 8.36% | 6.83% |
| Operating Income | 34.00% | 13.22% | 10.87% | 8.09% | 7.79% |
| Income Before Tax | 33.91% | 13.20% | 9.94% | 4.01% | 3.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.91% | 13.20% | 9.94% | 4.01% | 3.26% |
| Earnings from Discontinued Operations | -- | -15.38% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.32% | 13.06% | 20.91% | 14.61% | 13.23% |
| EBIT | 34.00% | 13.22% | 10.87% | 8.09% | 7.79% |
| EBITDA | 34.54% | 13.54% | 11.12% | 8.19% | 7.97% |
| EPS Basic | 31.90% | 21.87% | 29.56% | 24.07% | 23.29% |
| Normalized Basic EPS | 39.13% | 25.26% | 20.11% | 12.86% | 13.05% |
| EPS Diluted | 31.90% | 21.87% | 29.56% | 24.07% | 23.29% |
| Normalized Diluted EPS | 39.13% | 25.26% | 20.11% | 12.86% | 13.05% |
| Average Basic Shares Outstanding | 8.59% | 11.19% | 12.34% | 12.36% | 12.51% |
| Average Diluted Shares Outstanding | 8.59% | 11.19% | 12.34% | 12.36% | 12.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |